378
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Psychological Interventions on Abstinence in Patients with Alcohol Use Disorder: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , , ORCID Icon, & ORCID Icon show all
Pages 1815-1830 | Received 30 May 2022, Accepted 08 Aug 2022, Published online: 23 Aug 2022

References

  • GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223–1249. doi:10.1016/S0140-6736(20)30752-2
  • Rumgay H, Shield K, Charvat H, et al. Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study. Lancet Oncol. 2021;22(8):1071–1080. doi:10.1016/S1470-2045(21)00279-5
  • Castillo-Carniglia A, Keyes KM, Hasin DS, Cerdá M. Psychiatric comorbidities in alcohol use disorder. Lancet Psychiatry. 2019;6(12):1068–1080. doi:10.1016/S2215-0366(19)30222-6
  • World Health Organization. Global status report on alcohol and health 2018. World Health Organization; 2018. Available from: https://www.who.int/publications/i/item/9789241565639. Accessed August 12, 2022.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: USA: American Psychiatric Association Press; 2003.
  • World Health Organization. Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings. Geneva: World Health Organization; 2009.
  • Femino J, Freedman K, Goldsmith RJ, et al. The ASAM clinical practice guideline on alcohol withdrawal management: erratum. J Addict Med. 2020;14(5):e280. doi:10.1097/ADM.0000000000000731
  • American Psychiatric Association. Practice Guideline for the Treatment of Patients with Substance Use Disorders. 2nd ed. American Psychiatric Association; 2006: 291–563.
  • Knox J, Hasin DS, Larson FRR, Kranzler HR. Prevention, screening, and treatment for heavy drinking and alcohol use disorder. Lancet Psychiatry. 2019;6(12):1054–1067. doi:10.1016/S2215-0366(19)30213-5
  • Ray LA, Meredith LR, Kiluk BD, Walthers J, Carroll KM, Magill M. Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Netw Open. 2020;3(6):e208279. doi:10.1001/jamanetworkopen.2020.8279
  • Magill M, Ray L, Kiluk B, et al. A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: treatment efficacy by contrast condition. J Consult Clin Psychol. 2019;87(12):1093–1105. doi:10.1037/ccp0000447
  • Kiluk BD, Ray LA, Walthers J, Bernstein M, Tonigan JS, Magill M. Technology-delivered cognitive-behavioral interventions for alcohol use: a meta-analysis. Alcohol Clin Exp Res. 2019;43(11):2285–2295. doi:10.1111/acer.14189
  • Riper H, Andersson G, Hunter SB, de Wit J, Berking M, Cuijpers P. Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis. Addiction. 2014;109(3):394–406. doi:10.1111/add.12441
  • Powers MB, Vedel E, Emmelkamp PM. Behavioral couples therapy (BCT) for alcohol and drug use disorders: a meta-analysis. Clin Psychol Rev. 2008;28(6):952–962. doi:10.1016/j.cpr.2008.02.002
  • Cavicchioli M, Movalli M, Maffei C. The clinical efficacy of mindfulness-based treatments for alcohol and drugs use disorders: a meta-analytic review of randomized and nonrandomized controlled trials. Eur Addict Res. 2018;24(3):137–162. doi:10.1159/000490762
  • Block I, Loeber S. Evidenzbasierte Psychotherapie bei Abhängigkeitserkrankungen [Evidence-based psychotherapy of addictive disorders]. Nervenarzt. 2018;89(3):283–289. doi:10.1007/s00115-018-0483-7
  • Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;10:372.
  • Dilling H, Mombour W, Schmidt MH, Schulte-Markwort E. Internationale Klassifikation psychischer Störungen: ICD-10. In: Kapitel V (F) Klinisch-Diagnostische Leitlinien. [The ICD-10 Classification of Mental and Behavioural Disorders]. 3rd ed. Bern, Switzerland: Hans Huber; 2004.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Arlington, VA, USA: American Psychiatric Association Press; 1987.
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Arlington, VA, USA: American Psychiatric Association Press; 1994.
  • Lecrubier Y, Sheehan D, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatry. 1997;12(5):224–231. doi:10.1016/s0924-9338(97)83296-8
  • Selzer ML. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry. 1971;127(12):1653–1658. doi:10.1176/ajp.127.12.1653
  • Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): who collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction. 1993;88(6):791–804. doi:10.1111/j.1360-0443.1993.tb02093.x
  • Norcross JC. An eclectic definition of psychotherapy. In: Zeig JK, Munion WM, editors. What is Psychotherapy? Contemporary Perspectives. Jossey-Bass; 1990:218–220.
  • Merrill JE, Fan P, Wray TB, Miranda R. Assessment of alcohol use and consequences: comparison of data collected via timeline followback interview and daily reports. J Stud Alcohol Drugs. 2020;81(2):212–219. doi:10.15288/jsad.2020.81.212
  • Singleton EG, Henningfield JE, Tiffany S. Alcohol craving questionnaire: ACQ-Now: background and administration manual. NIDA Addiction Research Centre; 1994.
  • Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d5928
  • Cohen J. Statistical power analysis for the behavioral sciences–second edition. Hillsdale New Jersey: 12 Lawrence Erlbaum Associates Inc; 1988:77–83.
  • Carlin BP, Hong H, Shamliyan TA, Sainfort F, Kane RL. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013.
  • Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010;29(7–8):932–944. doi:10.1002/sim.3767
  • Puhan MA, Schünemann HJ, Murad MH, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2015;349:g5630. doi:10.1136/bmj.g5630
  • Feldstein Ewing S, Bryan AD, Dash GF, Lovejoy TI, Borsari B, Schmiege SJ. Randomized controlled trial of motivational interviewing for alcohol and cannabis use within a predominantly Hispanic adolescent sample. Exp Clin Psychopharmacol. 2021. doi:10.1037/pha0000445.
  • Santa Ana EJ, LaRowe SD, Gebregziabher M, et al. Randomized controlled trial of group motivational interviewing for veterans with substance use disorders. Drug Alcohol Depend. 2021;223:108716. doi:10.1016/j.drugalcdep.2021.108716
  • (DG-SUCHT). S3 guideline “Screening, diagnosis and treatment of alcohol-related disorders”. German Society for Psychiatry and Psychotherapy, Psychosomatics and Neurology (DGPPN) German Society for Addiction Research and Addiction Therapy e.V. AWMF; 2020. Available from: https://www.awmf.org/uploads/tx_szleitlinien/076-001l_S3-Screening-Diagnose-Behandlung-alkoholbezogene-Stoerungen_2021-02.pdf. Accessed August 28, 2021.
  • Loeber S, Mann K. Entwicklung einer evidenzbasierten Psychotherapie bei Alkoholismus. Eine Ubersicht [The development of evidence-based psychotherapy for use in alcoholism. A review]. Nervenarzt. 2006;77(5):558–566. doi:10.1007/s00115-005-2000-z
  • Magill M, Ray LA. Cognitive-behavioral treatment with adult alcohol and illicit drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol Drugs. 2009;70(4):516–527. doi:10.15288/jsad.2009.70.516
  • Chermack ST, Grogan-Kaylor A, Perron BE, Murray RL, De Chavez P, Walton MA. Violence among men and women in substance use disorder treatment: a multi-level event-based analysis. Drug Alcohol Depend. 2010;112(3):194–200. doi:10.1016/j.drugalcdep.2010.06.005
  • Chermack ST, Murray RL, Walton MA, Booth BA, Wryobeck J, Blow FC. Partner aggression among men and women in substance use disorder treatment: correlates of psychological and physical aggression and injury. Drug Alcohol Depend. 2008;98(1–2):35–44. doi:10.1016/j.drugalcdep.2008.04.010
  • Rothman EF, Cheng DM, Pedley A, et al. Interpersonal violence exposure and alcohol treatment utilization among medical inpatients with alcohol dependence. J Subst Abuse Treat. 2008;34(4):464–470. doi:10.1016/j.jsat.2007.07.006
  • Easton CJ, Mandel DL, Hunkele KA, Nich C, Rounsaville BJ, Carroll KM. A cognitive behavioral therapy for alcohol-dependent domestic violence offenders: an integrated substance abuse-domestic violence treatment approach (SADV). Am J Addict. 2007;16(1):24–31. doi:10.1080/10550490601077809
  • Sannibale C, Teesson M, Creamer M, et al. Randomized controlled trial of cognitive behaviour therapy for comorbid post-traumatic stress disorder and alcohol use disorders. Addiction. 2013;108(8):1397–1410. doi:10.1111/add.12167
  • O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. 1992;49(11):881–887. doi:10.1001/archpsyc.1992.01820110045007
  • Mellentin AI, Skøt L, Nielsen B, et al. Cue exposure therapy for the treatment of alcohol use disorders: a meta-analytic review. Clin Psychol Rev. 2017;57:195–207. doi:10.1016/j.cpr.2017.07.006